Status:
COMPLETED
Risk Factors for Enhanced Inflammation to Arthroplasty Wear Particles: Analysis of Cytokine Production and Polymorphisms
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborating Sponsors:
Technical University of Munich
University of Rostock
Conditions:
Allergy
Implants
Eligibility:
All Genders
18+ years
Brief Summary
Assessment of cytokine polymorphisms in 100 patients with aseptic complications to arthroplasty as compared to 100 symptom-free arthroplasty patients. In selected patients additional in-vitro cytokin...
Detailed Description
A cytokine polymorphism analysis in 100 individuals with aseptic implant intolerance reaction (patients of the implant allergy special ambulance) and in 100 asymptomatic patients with implanted endopr...
Eligibility Criteria
Inclusion
- arthroplasty
- over 18 years
- no infection
Exclusion
- inability to consent
- malposition
- infection
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 22 2019
Estimated Enrollment :
195 Patients enrolled
Trial Details
Trial ID
NCT02262065
Start Date
July 1 2012
End Date
February 22 2019
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ludwig-Maximilians-University Munich, Dept. of Dermatology
Munich, Bavaria, Germany, 80337